Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: An open-label trial

Biological Psychiatry

Volumn 39, Issue 3, 1996, Pages 213-215

  Leiderman, Eduardo ^a   Zylberman, Ilana ^a   Zukin, Stephen R ^a   Cooper, Thomas B ^b   Javitt, Daniel C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Glutamate; NMDA receptor; Phencyclidine (PCP) treatment; Positive and Negative Syndrome Scale (PANSS)

Indexed keywords

CLOZAPINE; GLYCINE; HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; HUMAN; NEGATIVE SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030032401     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00585-4     Document Type: Article

References (10)

1. Andreasen N (1989): The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry 155(suppl 7):49-52.
2. Costa J, Khaled E, Sramek J, Bunney W Jr, Potkin SG (1990): An open trial of glycine and an adjunct to neuroleptics in chronic treatment-refractory schizophrenics. J Clin Psychopharmacol 10:71-7
3. D'Souza DC, Morrissey K, Abi-Saab D, et al (1995): Intravenous glycine and oral D-cycloserine effects on CSF amino acids, plasma hormones, and behavior in healthy humans: implications for schizophrenia. Schizophr Res 15:147.
4. Hariharan M, Naga S, VanNoord (1993): Systematic approach to the development of plasma amino acid analyses by high-performance liquid chromatography with ultraviolet detection with precolumn derivatization using phenyl isothiocyanate. J Chromatogr 621:15-22.
5. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
6. Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP (1994): Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151:1234-1236.
7. Kay SR, Fiszbein A, Opler LA (1987): The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
8. Potkin SG, Costa J, Roy S, Sramek J, Jin Y, Gulasekaram B (1992): Glycine in the treatment of schizophrenia - theory and preliminary results, In Meltzer Hy (ed), Novel Antipsychotic Drugs. New York: Raven Press, pp 179-188.
9. Rosse RB, Theut SK, Banay-Schwartz M, et al (1989): Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: An open-label, pilot study. Clin Neuropharmacol 12:416-424.
10. Waziri R (1989): Glycine therapy of schizophrenia [letter]. Biol Psychiatry 23:210-211.